Literature DB >> 8628885

Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumors.

R Robledo1, A Muro, M L Prieto.   

Abstract

PURPOSE: To assess the accuracy of ultrasonography (US) in the demonstration of extrahepatic biliary tree cholangiocarcinoma and to analyze US features of the different morphologic types of this tumor.
MATERIALS AND METHODS: US findings were reviewed retrospectively in 49 patients with pathologically proved cholangiocarcinoma. Findings from percutaneous transhepatic cholangiography (n = 47) and endoscopic retrograde cholangiopancreatography (ERCP) (n = 2) were compared with those from US.
RESULTS: US demonstrated the tumor in 47 (96%) of the 49 patients; a mass was demonstrated in 44 patients, and a focal or diffuse thickening of the bile duct wall was seen in three patients.
CONCLUSION: The accuracy of US in depicting cholangiocarcinoma was attributable to the skill of the radiologists who performed the study and evaluated the findings and to the high frequency of tumor at the hilar level, where the liver and gallbladder allowed a clear acoustic window that facilitated detection of tumors.

Entities:  

Mesh:

Year:  1996        PMID: 8628885     DOI: 10.1148/radiology.198.3.8628885

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  Percutaneous ultrasound-guided cholangiography using microbubbles to evaluate the dilated biliary tract: initial experience.

Authors:  Zhou Luyao; Xie Xiaoyan; Xu Huixiong; Xu Zuo-Feng; Liu Guang-Jian; Lu Ming-de
Journal:  Eur Radiol       Date:  2011-09-24       Impact factor: 5.315

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 3.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 4.  Multimodality imaging of intrahepatic cholangiocarcinoma.

Authors:  Kelly Fábrega-Foster; Mounes Aliyari Ghasabeh; Timothy M Pawlik; Ihab R Kamel
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

5.  The risk factors and diagnosis of cholangiocarcinoma.

Authors:  Christopher A Wadsworth; Adrian Lim; Simon D Taylor-Robinson; Shahid A Khan
Journal:  Hepatol Int       Date:  2012-11-10       Impact factor: 6.047

Review 6.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  Diagnostic approaches for cholangiocarcinoma.

Authors:  Andreas Weber; Roland-M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

8.  Diagnosis of cholangiocarcinoma.

Authors:  B E Van Beers
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  Diagnosis of biliary tract and ampullary carcinomas.

Authors:  Kazuhiro Tsukada; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Masato Nagino; Satoshi Kondo; Junji Furuse; Hiroya Saito; Toshio Tsuyuguchi; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16

10.  Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

Authors:  Roman Kloeckner; Christian Ruckes; Kai Kronfeld; Marcus Alexander Wörns; Arndt Weinmann; Peter Robert Galle; Hauke Lang; Gerd Otto; Waltraud Eichhorn; Mathias Schreckenberger; Christoph Dueber; Michael Bernhard Pitton
Journal:  Trials       Date:  2014-08-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.